Work

Adverse events and dropouts in Alzheimer's disease studies: What can we learn?

Year: 2014

Type: article

Source: Alzheimer s & Dementia

DOI: 10.1016/j.jalz.2013.11.008

Authors: David B. Henley, Karen L. Sundell, Gopalan Sethuraman, Lon S. Schneider

Institutions: Eli Lilly (United States), University of Southern California

Language: English

Topic: Alzheimer's disease research and treatments

Subfield: Physiology (medical)

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

Funders: Eli Lilly and Company, Pfizer, Baxter International, Genentech

OpenAlex ID: W2114155672

FWCI: 0.623

Cites: 19

Cited by: 16

Related to: 10